Vernakalant hydrochloride for rapid conversion of atrial fibrillation: A phase 3, randomized, placebo-controlled trial Academic Article uri icon

Overview

MeSH Major

  • Anisoles
  • Anti-Arrhythmia Agents
  • Atrial Fibrillation
  • Pyrrolidines

abstract

  • Vernakalant demonstrated rapid conversion of short-duration AF and was well tolerated.

publication date

  • March 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1161/CIRCULATIONAHA.107.723866

PubMed ID

  • 18332267

Additional Document Info

start page

  • 1518

end page

  • 25

volume

  • 117

number

  • 12